-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U8+83fu5K2pAQTMX4xdNxZAqMeAX/farOZ0kE69LJAVeRu8R/IKN8O3u2UM0YBL9 ztw49h2kNcUlnaRAbhYOQg== 9999999995-07-003146.txt : 20070808 9999999995-07-003146.hdr.sgml : 20070808 20070808001516 ACCESSION NUMBER: 9999999995-07-003146 CONFORMED SUBMISSION TYPE: EFFECT PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070807 DATE AS OF CHANGE: 20070808 EFFECTIVENESS DATE: 20070807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chelsea Therapeutics International, Ltd. CENTRAL INDEX KEY: 0001333763 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203174202 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: EFFECT SEC ACT: 1933 Act SEC FILE NUMBER: 333-141964 FILM NUMBER: 071033427 BUSINESS ADDRESS: STREET 1: 13950 BALLANTYNE CORPORATE PLACE STREET 2: UNIT 325 CITY: CHARLOTTE STATE: NC ZIP: 28277 BUSINESS PHONE: 704-341-1516 MAIL ADDRESS: STREET 1: 13950 BALLANTYNE CORPORATE PLACE STREET 2: UNIT 325 CITY: CHARLOTTE STATE: NC ZIP: 28277 EFFECT 1 primary_doc.xml X0101 EFFECT 33 LIVE 2007-08-07 16:30:00
S-3
0001333763 Chelsea Therapeutics International, Ltd. 333-141964
-----END PRIVACY-ENHANCED MESSAGE-----